Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Step up Research on Magnetic Metal Complexes Using Versatile Materials

    Sep 20, 2022, 10:19 AM by
    Full story
  • High-Quality Dexmedetomidine Hydrochloride (API) Meeting CP & EP Standards

    Sep 20, 2022, 10:19 AM by
    Full story
  • Liposomes as Drug Delivery Vehicles

    Sep 20, 2022, 10:18 AM by
    Full story
  • BioIVT Launches GMP-grade VivoSTART Leukopaks for Cell and Gene Therapy Manufacturing

    Sep 20, 2022, 10:18 AM by
    VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.
    Full story
  • Glioblastoma Cancer Cells ‘Starve’ Without Astrocyte Immunometabolic Support

    Sep 20, 2022, 01:00 AM by User Not Found
    Bio-IT World | Tel Aviv University researchers discovered that glioblastoma cells—a highly resistant, aggressive, and deadly form of cancer—“starve” to death without immunometabolic support from astrocytes.
    Full story
  • Integrated DNA Technologies Expands Customization Options for Alt-R™ Custom CRISPR gRNA Libraries for Drug Discovery

    Sep 19, 2022, 10:26 AM by
    Full story
  • Inizio Biotech makes key leadership appointment to meet demand from emerging biotech

    Sep 16, 2022, 10:08 AM by
    Full story
  • Anti-inflammatory drug candidate DMXD-011 shows efficacy in ex-vivo human studies

    Sep 15, 2022, 11:05 AM by
    Full story
  • TFDA Grants CTL Amedica License to Market MATISSE™ ACIF Cage System

    Sep 15, 2022, 11:03 AM by
    The Taiwan Food and Drug Administration has granted CTL Amedica Corporation a license to market the MATISSE Anterior Cervical Interbody Fusion (ACIF) Cage System.
    Full story
  • Clinion - Platinum Sponsor for ISCR 3rd Autumn Conference 2022

    Sep 15, 2022, 11:02 AM by
    Full story
  • BrightInsight Selects Lyniate to Enhance Interoperability Strategic Engagement Will Improve Information Exchange for Regulated Digital Health Solutions Built on the BrightInsight® Platform

    Sep 15, 2022, 10:52 AM by
    Full story
  • Graphene Modification Helps to Unlock New Potentials

    Sep 15, 2022, 10:36 AM by
    Full story
  • Accelerated Shelf-Life Testing to Assess Drug Stability

    Sep 15, 2022, 10:35 AM by
    Full story
  • Four Most Commonly Used Surfactants You Should Know

    Sep 15, 2022, 10:35 AM by
    Full story
  • Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

    Sep 15, 2022, 10:34 AM by
    Full story
  • BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates

    Sep 15, 2022, 10:29 AM by
    XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies.
    Full story
  • Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

    Sep 15, 2022, 10:28 AM by
    Molecular Devices and HeartBeat.bio AG have entered into a co-development agreement to commercialize a first-of-its-kind automated offering that will enable researchers to reliably scale production of Cardioids and advance cardiac drug discovery.
    Full story
  • Mount Sinai Aims To Enroll One Million People In Genetic Sequencing Project

    Sep 15, 2022, 01:00 AM by User Not Found
    Bio-IT World | The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai. If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health.
    Full story
  • Public More Protective Of Their Health Information Than Their Biospecimens

    Sep 14, 2022, 01:00 AM by User Not Found
    Bio-IT World | In the ongoing debate about whether biospecimens should be covered by human subjects research regulations, bioethicists at the University of Michigan recently added a critical datapoint in disproving one of the arguments—namely, that the public feels more protective of their biospecimens than their health information.
    Full story
  • Digestive Hormones Found to Significantly Influence Infectious Wound Healing

    Sep 13, 2022, 01:00 AM by User Not Found
    Bio-IT World | The University of Calgary research team discovered that neutrophils and monocytes—two types of white blood cells—play distinct roles in wound healing, with digestive hormones contributing to immune function.
    Full story
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116 (current)
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy